Partners in crime: Bidirectional transcription in unstable microsatellite disease

Human Molecular Genetics

Volumn 19, Issue R1, 2010, Pages

  Batra, Ranjan ^a   Charizanis, Konstantinos ^a   Swanson, Maurice S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 8; BIOLOGICAL MARKER; COMPLEMENTARY RNA; FRAGILE X MENTAL RETARDATION PROTEIN; HUNTINGTON DISEASE LIKE 2 PROTEIN; POLYGLUTAMINE; UNCLASSIFIED DRUG;

ARTICLE; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; GENE MUTATION; GENE SILENCING; HUMAN; HUNTINGTON CHOREA; KENNEDY DISEASE; MICROSATELLITE MARKER; MYOTONIC DYSTROPHY; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PATHOGENESIS; PRIORITY JOURNAL; RNA SPLICING; SPINOCEREBELLAR DEGENERATION; TRANSCRIPTION REGULATION; TRINUCLEOTIDE REPEAT;

DNA, SATELLITE; FRAGILE X SYNDROME; HUMANS; HUNTINGTON DISEASE; TRANSCRIPTION, GENETIC;

EID: 77953887860     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq132     Document Type: Article

References (51)

1. Mirkin, S.M. (2007) Expandable DNA repeats and human disease. Nature, 447, 932-940.
2. Lopez Castel, A., Cleary, J.D. and Pearson, C.E. (2010) Repeat instability as the basis for human diseases and as a potential target for therapy. Nat. Rev. Mol. Cell. Biol., 11, 165-170.
3. Orr, H.T. and Zoghbi, H.Y. (2007) Trinucleotide repeat disorders. Ann. Rev. Neurosci., 30, 575-621.
4. Brouwer, J.R., Willemsen, R. and Oostra, B.A. (2009) Microsatellite repeat instability and neurological disease. Bioessays, 31, 71-83.
5. Messaed, C. and Rouleau, G.A. (2009) Molecular mechanisms underlying polyalanine diseases. Neurobiol. Dis., 34, 397-405.
6. Bennett, E.J., Shaler, T.A., Woodman, B., Ryu, K.Y., Zaitseva, T.S., Becker, C.H., Bates, G.P., Schulman, H. and Kopito, R.R. (2007) Global changes to the ubiquitin system in Huntington's disease. Nature, 448, 704-708.
7. Gil, J.M. and Rego, A.C. (2008) Mechanisms of neurodegeneration in Huntington's disease. Eur. J. Neurosci., 27, 2803-2820.
8. Kumari, D. and Usdin, K. (2009) Chromatin remodeling in the noncoding repeat expansion diseases. J. Biol. Chem., 284, 7413-7417.
9. Zoghbi, H.Y. and Orr, H.T. (2009) Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J. Biol. Chem., 284, 7425-7429.
10. Milnerwood, A.J., Gladding, C.M., Pouladi, M.A., Kaufman, A.M., Hines, R.M., Boyd, J.D., Ko, R.W., Vasuta, O.C., Graham, R.K., Hayden, M.R. et al. (2010) Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron, 65, 178-190.
11. Okamoto, S., Pouladi, M.A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D.E., Zaidi, R., Clemente, A., Kaul, M., Graham, R.K. et al. (2009) Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med., 15, 1407-1413.
12. Cooper, T.A., Wan, L. and Dreyfuss, G. (2009) RNA and disease. Cell, 136, 777-793.
13. O'Rourke, J.R. and Swanson, M.S. (2009) Mechanisms of RNA-mediated disease. J. Biol. Chem., 284, 7419-7423.
14. He, Y., Vogelstein, B., Velculescu, V.E., Papadopoulos, N. and Kinzler, K.W. (2008) The antisense transcriptomes of human cells. Science, 322, 1855-1857.
15. Faghihi, M.A. and Wahlestedt, C. (2009) Regulatory roles of natural antisense transcripts. Nat. Rev. Mol. Cell. Biol., 10, 637-643.
16. Taft, R.J., Pang, K.C., Mercer, T.R., Dinger, M. and Mattick, J.S. (2010) Non-coding RNAs: regulators of disease. J. Pathol., 220, 126-139.
17. Cho, D.H., Thienes, C.P., Mahoney, S.E., Analau, E., Filippova, G.N. and Tapscott, S.J. (2005) Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell, 20, 483-489.
18. Moseley, M.L., Zu, T., Ikeda, Y., Gao, W., Mosemiller, A.K., Daughters, R.S., Chen, G., Weatherspoon, M.R., Clark, H.B., Ebner, T.J. et al. (2006) Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat. Genet., 38, 758-769.
19. Ladd, P.D., Smith, L.E., Rabaia, N.A., Moore, J.M., Georges, S.A., Hansen, R.S., Hagerman, R.J., Tassone, F., Tapscott, S.J. and Filippova, G.N. (2007) An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet., 16, 3174-3187.
20. Dion, V. and Wilson, J.H. (2009) Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet., 25, 288-297.
21. Lavorgna, G., Dahary, D., Lehner, B., Sorek, R., Sanderson, C.M. and Casari, G. (2004) In search of antisense. Trends Biochem. Sci., 29, 88-94.
22. Lapidot, M. and Pilpel, Y. (2006) Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms. EMBO Rep., 7, 1216-1222.
23. Morris, K.V., Santoso, S., Turner, A.M., Pastori, C. and Hawkins, P.G. (2008) Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet., 4, e1000258.
24. Wang, Y.H., Amirhaeri, S., Kang, S., Wells, R.D. and Griffith, J.D. (1994) Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science, 265, 669-671.
25. Otten, A.D. and Tapscott, S.J. (1995) Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl Acad. Sci. USA, 92, 5465-5469.
26. Klesert, T.R., Otten, A.D., Bird, T.D. and Tapscott, S.J. (1997) Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat. Genet., 16, 402-406.
27. Thornton, C.A., Wymer, J.P., Simmons, Z., McClain, C. and Moxley, R.T. 3rd (1997) Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat. Genet., 16, 407-409.
28. Koob, M.D., Moseley, M.L., Schut, L.J., Benzow, K.A., Bird, T.D., Day, J.W. and Ranum, L.P. (1999) An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet., 21, 379-384.
29. Nykamp, K.R. and Swanson, M.S. (2004) Toxic RNA in the nucleus: unstable microsatellite expression in neuromuscular disease. Prog. Mol. Subcell. Biol., 35, 57-77.
30. Mutsuddi, M., Marshall, C.M., Benzow, K.A., Koob, M.D. and Rebay, I. (2004) The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr. Biol., 14, 302-308.
31. Daughters, R.S., Tuttle, D.L., Gao, W., Ikeda, Y., Moseley, M.L., Ebner, T.J., Swanson, M.S. and Ranum, L.P. (2009) RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet., 5, e1000600.
32. Marsh, J.L., Walker, H., Theisen, H., Zhu, Y.Z., Fielder, T., Purcell, J. and Thompson, L.M. (2000) Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet., 9, 13-25.
33. Nemes, J.P., Benzow, K.A., Moseley, M.L., Ranum, L.P. and Koob, M.D. (2000) The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1). Hum. Mol. Genet., 9, 1543-1551.
34. Day, J.W., Schut, L.J., Moseley, M.L., Durand, A.C. and Ranum, L.P. (2000) Spinocerebellar ataxia type 8: clinical features in a large family. Neurology, 55, 649-657.
35. Worth, P.F., Houlden, H., Giunti, P., Davis, M.B. and Wood, N.W. (2000) Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia. Nat. Genet., 24, 214-215.
36. Ikeda, Y., Daughters, R.S. and Ranum, L.P. (2008) Bidirectional expression of the SCA8 expansion mutation: one mutation, two genes. Cerebellum, 7, 150-158.
37. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P. et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
38. Oostra, B.A. and Willemsen, R. (2003) A fragile balance: FMR1 expression levels. Hum. Mol. Genet., 12 (Spec No 2), R249-R257.
39. Jacquemont, S., Hagerman, R.J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J.A., Greco, C., Des Portes, V., Jardini, T., Levine, R. et al. (2003) Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet., 72, 869-878.
40. Iwahashi, C.K., Yasui, D.H., An, H.J., Greco, C.M., Tassone, F., Nannen, K., Babineau, B., Lebrilla, C.B., Hagerman, R.J. and Hagerman, P.J. (2006) Protein composition of the intranuclear inclusions of FXTAS. Brain, 129, 256-271.
41. Tassone, F., Beilina, A., Carosi, C., Albertosi, S., Bagni, C., Li, L., Glover, K., Bentley, D. and Hagerman, P.J. (2007) Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA, 13, 555-562.
42. Khalili, K., Del Valle, L., Muralidharan, V., Gault, W.J., Darbinian, N., Otte, J., Meier, E., Johnson, E.M., Daniel, D.C., Kinoshita, Y. et al. (2003) Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol. Cell. Biol., 23, 6857-6875.
43. Jin, P., Duan, R., Qurashi, A., Qin, Y., Tian, D., Rosser, T.C., Liu, H., Feng, Y. and Warren, S.T. (2007) Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron, 55, 556-564.
44. Sofola, O.A., Jin, P., Qin, Y., Duan, R., Liu, H., de Haro, M., Nelson, D.L. and Botas, J. (2007) RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron, 55, 565-571.
45. Oostra, B.A. and Willemsen, R. (2009) FMR1: a gene with three faces. Biochim. Biophys. Acta, 1790, 467-477.
46. Wenzel, H.J., Hunsaker, M.R., Greco, C.M., Willemsen, R. and Berman, R.F. Ubiquitin-positive intranuclear inclusions in neuronal and glial cells in a mouse model of the fragile X premutation. Brain Res., 1318, 155-166.
47. Hashem, V., Galloway, J.N., Mori, M., Willemsen, R., Oostra, B.A., Paylor, R. and Nelson, D.L. (2009) Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum. Mol. Genet., 18, 2443-2451.
48. Khalil, A.M., Faghihi, M.A., Modarresi, F., Brothers, S.P. and Wahlestedt, C. (2008) A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One, 3, e1486.
49. Greenstein, P.E., Vonsattel, J.P., Margolis, R.L. and Joseph, J.T. (2007) Huntington's disease like-2 neuropathology. Mov. Disord., 22, 1416-1423.
50. Rudnicki, D.D., Holmes, S.E., Lin, M.W., Thornton, C.A., Ross, C.A. and Margolis, R.L. (2007) Huntington's disease-like 2 is associated with CUG repeat-containing RNA foci. Ann. Neurol., 61, 272-282.
51. Rudnicki, D.D., Pletnikova, O., Vonsattel, J.P., Ross, C.A. and Margolis, R.L. (2008) A comparison of Huntington disease and Huntington- disease-like 2 neuropathology. J. Neuropathol. Exp. Neurol., 67, 366-374.